MedMen Acquires Pharmacann In $682 Million Deal

California-based MedMen Enterprises (MMNFF) has acquired Pharmacann in an all-stock transaction valued at $682 million. The deal expands MedMen’s footprint in the Midwest and the East Coast as the race to become the biggest multi-state player heats up.
With the merger, facilities in Illinois, New York, Pennsylvania, Maryland, Massachusetts, Ohio, Virginia, and Michigan will expand the MedMen portfolio. Pharmacann will own approximately 25% of the pro-forma company, on a fully-diluted basis, at closing.
“This is a transformative acquisition that will create the largest U.S. cannabis company in the world’s largest cannabis market,” said Adam Bierman, MedMen’s chief executive officer, and co-founder. “The transaction adds tremendous scale to our vertically integrated business model by expanding our U.S. retail footprint across important growth markets while strengthening our cultivation and production capabilities. With the revenue synergies that the deal is expected to produce, MedMen is well positioned to continue executing on our growth strategy. This would not have been possible even two years ago and is a testament to how far both the industry and these two companies have evolved.”
Pharmacann is a medical marijuana operator with 10 retail stores and three cultivation and production facilities across multiple states. According to the company, MedMen’s network nearly doubles through this absorption with a portfolio of cannabis licenses in 12 states that will permit the combined company to operate 79 cannabis facilities, making them the largest cannabis company with a brick-and-mortar footprint in America.
The recent acquisition moves are a distinct departure from the company’s original plan to stick with just the high-density locations of Los Angeles, New York, and Las Vegas. Head of Communication Daniel Yi said, “We get asked that question a lot. Our plan was to establish ourselves and create a solid position in the three key areas. Now that we’ve accomplished that, it’s time to expand.”  Yi said that the company believes that brick and mortar retail is where most cannabis consumers will gravitate and make their purchases and the company intends to capture that market.
This deal follows last week’s announcement in which MedMen signed an agreement to purchase Scottsdale-based cannabis company Monarch from WhiteStar Solutions. The company agreed to pay WhiteStar approximately 80% in stock and 20% in cash in an undisclosed amount. The stock consideration would be satisfied by way of issuance of shares of MedMen Enterprises, Inc.
MedMen also said last week that it was purchasing Chicago-based dispensary Seven Point for an undisclosed amount of cash at closing, deferred cash, and shares of MedMen Enterprises, Inc. Not done yet, MedMen closed a C$93,822,023 (US$73,275,000) senior secured term loan facility with funds managed by Hankey Capital and with an affiliate of Stable Road Capital as the largest loan participant.
“PharmaCann has built highly-efficient cultivation centers and dispensaries to promote a better quality of life for medical marijuana patients,” said Teddy Scott, Ph. D., PharmaCann chief executive officer. “This acquisition validates the dedication and level of sophistication we have used to provide consistent patient outcomes. I am proudest of the top-notch team we have assembled here and their dedication to our mission of serving medical marijuana patients. Our organization is a natural fit for MedMen, and we are excited to join a leading enterprise with a best-in-class management team.”
Stock Performance
MedMen stock jumped almost 5% at the opening of trading on the news to lately trade at $4.40 on the OTC Market. The company is currently listed at roughly 70 million outstanding shares and with so many of these recent deals being done on the premise of issuing more shares, that number is expected to increase.
The company didn’t say at this time, what the amount of outstanding shares is expected to become, but company spokesman Daniel Yi said that issuing more shares to fund the company expansion was always part of the strategy.

Debra Borchardt

Debra Borchardt is the Co-Founder, and Executive Editor of GMR. She has covered the cannabis industry for several years at Forbes, Seeking Alpha and TheStreet. Prior to becoming a financial journalist, Debra was a Vice President at Bear Stearns where she held a Series 7 and Registered Investment Advisor license. Debra has a Master's degree in Business Journalism from New York University.

Leave a Reply

Your email address will not be published. Required fields are marked *

Get the latest cannabis news delivered right to your inbox

The Morning Rise

Unpack the industry with the daily cannabis newsletter for business leaders.

 Sign up

About Us

The Green Market Report focuses on the financial news of the rapidly growing cannabis industry. Our target approach filters out the daily noise and does a deep dive into the financial, business and economic side of the cannabis industry. Our team is cultivating the industry’s critical news into one source and providing open source insights and data analysis


Recent Tweets

Get the latest cannabis news delivered right to your inbox

The Morning Rise

Unpack the industry with the daily cannabis newsletter for business leaders.